Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Antibiotic use in kids linked to superbug carriage?

NCT ID NCT07234734

Knowledge-focused Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tracked 581 hospitalized children aged 1-16 to see how antibiotic treatment affects the development of MRSA in the nose. Researchers compared children who received antibiotics to those who did not. The goal is to understand how antibiotic use drives antimicrobial resistance in young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could help doctors prescribe antibiotics more wisely in children, reducing the spread of resistant bacteria like MRSA.
What could go wrong
This is an observational study, not a treatment trial. It only measures patterns, so it cannot prove cause and effect or directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

581 people

The number who actually took part.

Started

Sep 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The population enrolled in this study will include all the patients admitted to the Paediatric Unit of the involved Hospitals during the study period that respect inclusion and exclusion criteria

Ages

1 year to 16 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: · All the hospitalized children, aged between 1 and 16 years. * Informed consent signed by parents or legal tutors Exclusion Criteria: · All the hospitalized children admitted to the Unit of Oncologic/Hematologic disease or children affected with an hematologic disease also if admitted to the General Paediatric Ward. * All the hospitalized children admitted to the Paediatric Intensive Care Unit (PICU) * All the hospitalized children aged \< 1 years old * Children with parents or legal tutor who eventually refuse to sign the study consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nasal methicillin-resistant staphylococcus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

methicillin-resistant staphylococcus aureus infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nasal methicillin-resistant staphylococcus

Contacts and locations

Locations

  • Fondazione IRCCS Policlinico San Matteo, SC Malattie Infettive

    Pavia, Pavia, 27100, Italy